The Successful Use of Adalimumab to Treat Active Crohn's Disease of an Ileoanal Pouch During Pregnancy
Open Access
- 29 September 2006
- journal article
- case report
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (11), 2045-2047
- https://doi.org/10.1007/s10620-006-9452-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended studyAnnals Of The Rheumatic Diseases, 2006
- Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2005
- ReplyGastroenterology, 2005
- Safety and Efficacy of Adalimumab (D2E7) in Crohn's Disease Patients with an Attenuated Response to InfliximabAmerican Journal of Gastroenterology, 2005
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004
- An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Prior Loss of Response or Intolerance to Infliximab for Crohn's DiseaseAmerican Journal of Gastroenterology, 2004
- Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trialArthritis & Rheumatism, 2003
- Adalimumab (a fully human anti-tumour necrosis factor monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trialsAnnals Of The Rheumatic Diseases, 2002
- Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFa monoclonal antibodyHuman & Experimental Toxicology, 2000
- Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registriesAmerican Journal of Gastroenterology, 1998